维普中文期刊产品整合服务
14篇 您的检索式:作者名="Julio G D"
    题名 作者 年代 出处 被引量
1Frequency of cognitive im-pairment without dementia in patients with stroke a two -year fol - low - up study 显示文摘Soledad S Julio D Elena R G 2007J Stroke2007,38,:1
2MERRA: NASA’s Modern-Era Retrospective Analysis for Research and Applications显示文摘Rienecker Michele M Suarez Max J Gelaro Ronald Todling Ricardo Bacmeister Julio Liu Emily Bosilovich Michael G Schubert Siegfried D Takacs Lawrence Kim Gi-Kong Bloom Stephen Chen Junye Collins Douglas Conaty Austin Da Silva Arlindo Gu Wei 2011Journal of Climate2011,,14:1
3Study of the Joule effect on rapid chloride permeability values and evaluation of related electrical properties of concretes 显示文摘Julio G A Hooton R D 2004Cement and Concrete Research2004,34,6:1
4Study of the Joule effect on rapid chloride permeability values and eval- uation of related electrical properties of concrete显示文摘JULIO - BETANCOURT G A HOOTON R D 2004Ce- ment and Concrete Research2004,,34:1
5Study of the Joule effect on rapid chloride permeability values and evaluation of related electrical properties of concretes 显示文摘Julio - Betancourt G A Hooton R D 2004Cement and Concrete Research2004,4,6:1
6Image processing techniques in a preliminary morphometric characterization of corneal epithelium by scanning electron microscopy显示文摘Julio G Merindano D Canals M 2010Microsc Res Tech2010,73,11:1
7Frequency of cognitive impairment without dementia in patients with stroke a two-year fol-low-up study显示文摘Soledad S Julio D Elena R G 0,,:1
8Myenteric Antiplexus Antibodies and Class II HLA in Achalasia显示文摘Antonio Ruiz-de-León Juan Mendoza Concepción Sevilla-Mantilla Miguel Fernández Arquero Julio Pérez-de-la-Serna Ana Gónzalez Vigo Enrique Rey Angeles Figueredo Manuel Díaz-Rubio Emilio G. de-la-Concha 2002Digestive Diseases and Sciences2002,,1:1
9Cores of convex and strictly convex games显示文摘Julio G D Estela S R 2008Games and Economic Behavior2008,62,:1
10Frequency of cognitive impairmentwithout dementia inpatients with stroke a two-year fol- low-upstudy显示文摘Soledad S Julio D Elena R G 2007J Stroke2007,38,:1
11Frequency of cognitive impairment without dementia in patients with stroke a two-year follow-up study显示文摘SOLEDAD S JULIO D ELENA R G 2007J Stroke2007,38,:1
12Frequency of cognitive impair- ment without dementia in patients with stroke a two - year fol - low-up study 显示文摘Soledad S Julio D Elena R G 2007JStroke2007,38,:1
13Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil显示文摘BACKGROUND Crohn’s disease(CD)and ulcerative colitis(UC)are inflammatory bowel diseases(IBDs)with a remission-relapsing presentation and symptomatic exacerbations that have detrimental impacts on patient quality of life and are associated with a high cost burden,especially in patients with moderate-to-severe disease.The Real-world Data of Moderate-to-Severe Inflammatory Bowel Disease in Brazil(RISE BR)study was a noninterventional study designed to evaluate disease control,treatment patterns,disease burden and health-related quality of life in patients with moderate-to-severe active IBD.We report findings from the prospective follow-up phase of the RISE BR study in patients with active UC or CD.AIM To describe the 12-mo disease evolution and treatment patterns among patients with active moderate-to-severe IBD in Brazil.METHODS This was a prospective,noninterventional study of adult patients with active Crohn’s disease(CD:Harvey-Bradshaw Index≥8,CD Activity Index≥220),inadequate CD control(i.e.,calprotectin>200μg/g or colonoscopy previous results),or active ulcerative colitis(UC:Partial Mayo score≥5).Enrollment occurred in 14 centers from October 2016 to February 2017.The proportion of active IBD patients after 9-12 mo of follow-up,Kaplan-Meier estimates of the time to mild or no activity and a summary of treatment initiation,discontinuation and dose changes were examined.RESULTS The study included 118 CD and 36 UC patients,with mean±SD ages of 43.3±12.6 and 44.9±16.5 years,respectively.The most frequent drug classes at index were biologics for CD(62.7%)and 5-aminosalicylate derivates for UC patients(91.7%).During follow-up,65.3%of CD and 86.1%of UC patients initiated a new treatment at least once.Discontinuations/dose changes occurred in 68.1%of CD patients[median 2.0(IQR:2-5)]and 94.3%of UC patients[median 4.0(IQR:3-7)].On average,CD and UC patients had 4.4±2.6 and 5.0±3.3 outpatient visits,respectively.The median time to first mild or no activity was 319(IQR:239-358)d for CD and 320(IQR:288-358)d for UC patients.At 9-12 mo,22.0%of CD and 20.0%of UC patients had active disease.CONCLUSION Although a marked proportion of active IBD patients achieved disease control within one year,the considerable time to achieve this outcome represents an unmet medical need of the current standard of care in a Brazilian real-world setting.Ligia Yukie Sassaki Sender J Miszputen Roberto Luiz Kaiser Junior Wilson R Catapani Mauro Bafutto António S Scotton Cyrla Zaltman Julio Pinheiro Baima Hagata S Ramos Mikaell Alexandre Gouvea Faria Carolina D Gonçalves Isabella Miranda Guimaraes Cristina Flores Heda M B S Amarante Rodrigo Bremer Nones JoséMiguel Luz Parente Murilo Moura Lima Júlio Maria Chebli Maria de Lourdes Abreu Ferrari Julia F Campos Maria G P Sanna Odery Ramos Rogério Serafim Parra Jose J R da Rocha Omar Feres Marley R Feitosa Rosana Fusaro Caratin Juliana Tosta Senra Genoile Oliveira Santana 2021World Journal of Gastroenterology2021,27,23:0
14Evolution of Pre-Columbian Metallurgy from the North of Peru Studied with a Portable Non-invasive Equipment Using Energy-Dispersive X-Ray Fluorescence显示文摘Roberto Cesareo Angel Bustamante D Julio Fabian S Sandra Zambrano A Walter Alva Luis Chero del Carmen Espinoza C Rosendo Rodriguez R Marco Seclen F Fidel Gutierrez V E.B. Ldvano Gonzales A. Marcia A. Rizzutto Enrico Poli Cristiane Calza Marcelino dos Anjos Ricardo T. Lopes Giovanni E. Gigante Gabriel M. Ingo Cristina Riccucci Carlos Elera Izumi Shimada Victor Curay Castillo G and Fabio Lopes 2011材料科学与工程(中英文B版)2011,1,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费